肿瘤患者抗凝用药审方规则优化的药学实践

doi:10.3969/j.issn.2095-1264.2023.04.15

首页 > 过刊浏览>2023年第4期 >498-501. DOI:10.3969/j.issn.2095-1264.2023.04.15

肿瘤患者抗凝用药审方规则优化的药学实践
DOI:
                        10.3969/j.issn.2095-1264.2023.04.15
                    
作者:
                        
                        
                    
作者单位:武汉大学人民医院，湖北 武汉，430060
作者简介:戎佩佩，女，硕士，主管药师，研究方向：临床药学。
通讯作者:
中图分类号:R973+.2
基金项目:

Pharmaceutical practice of optimization of anticoagulants prescription review rules for cancer patients

Author:

Affiliation:

Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China

Fund Project:

摘要

图/表

访问统计

参考文献

相似文献

引证文献

资源附件

文章评论

摘要:

目的临床药师通过对肿瘤患者抗凝用药的临床问题进行文献回顾和规则优化，以提高审方系统的敏感性和特异性。方法临床药师定期对警示规则的触发原因进行基于文献的分析和梳理，并基于指南与循证证据优化警示内容。结果对前置审方系统的规则优化可提高医师对警示信息的接受度。结论临床药师可通过优化前置审方规则提高合理用药水平。

Abstract:

Objective To improve the sensitivity and specificity of prescription review system by reviewing the literature and optimizing the rules of anticoagulant drugs used in cancer patients.Methods Clinical pharmacists regularly analyze and comb the trigger reasons of warning rules based on literature, and optimize the warning content based on guidelines and evidence-based evidence.Results The optimization on the rules of prescription review system can improve the doctors' acceptance of warning information.Conclusion Clinical pharmacists can improve the level of rational drug use by optimizing the rules of prescription review system.